Q: What is the pen needles market size in 2021?

A: The pen needles market size is US$ 1,500 million in 2021.

Q: What is the CAGR for the pen needles market?

A: The pen needles market is expected to grow at a CAGR of 11.5 % during 2023-2032.

Q: What are the segments covered in the pen needles market report?

A: Market.US has segmented the Global pen needles Market Value (US$ Mn) Analysis by Region, 2022 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type, market has been segmented into standard pen needles and safety pen needles. By Needle Length, market has been further divided into 5 mm, 6 mm, 8mm, 10 mm, and other needle length. By Therapy, market has been further divided into Insulin, Growth hormone, and Glucagon-like-Peptide-1 (GLP-1).

Q: Who are the key players in the pen needles market?

A: Novo Nordisk A/S, Becton, Dickinson and Company, TERUMO CORPORATION, Owen Mumford Ltd., Ypsomed, B. Braun Melsungen AG, HTL-STREFA, Other Key Players are the key vendors in the Pen needles market.

Q: Which region is more attractive for vendors in the pen needles market?

A: North America is expected to account for the highest revenue share of 45% among the other regions. Therefore, the pen needles market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

Q: What are the key markets for pen needles?

A: Key markets for pen needles are the U.S., Canada, the U.K., Germany, Japan, India, China, Brazil, Mexico, and South Africa.

Q: Which segment has the largest share in the pen needles market?

A: In the pen needles market, vendors should focus on grabbing business opportunities from the 8 mm Needle length segment as it accounted for the largest market share in the base year.

Global Pen Needles Market By Product Type (Standard Pen Needles and Safety Pen Needles), By Needles Length (5 mm, 6 mm, 8 mm, and Other Needles Length), By Therapy (Insulin, Growth Hormone, and Glucagon-like-Peptide-1 (GLP-1)), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

Published date: Nov 2021
Report ID: 20487
Number of Pages: 232
Format:

- 1. Pen Needles Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Pen Needles Market Overview
  - 3.1. Pen Needles Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Pen Needles Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Pen Needles Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Standard Insulin Pen Needles
  - 4.4. Safety Insulin Pen Needles
- 5. Global Pen Needles Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Pen Needles Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Home Use
  - 5.4. Medical Institutions
- 6. Global Pen Needles Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Pen Needles Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2. Europe
    6.2.1. Europe Pen Needles Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Pen Needles Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    6.4.1. Latin America Pen Needles Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Pen Needles Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Pen Needles Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. BD
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Novo Nordisk
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. Artsana
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. B.Braun
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Terumo
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Ypsomed
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. Owen Mumford
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. HTL-Strefa
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
  - 7.11. Beipu
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. Kangdelai
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
  - 7.13. Ulticare
    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments
  - 7.14. Allison Medical
    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments
  - 7.15. Dongbao
    7.15.1. Company Overview
    7.15.2. Financial Highlights
    7.15.3. Product Portfolio
    7.15.4. SWOT Analysis
    7.15.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Novo Nordisk A/S Company Profile
- Becton, Dickinson and Company Profile
- Dickinson and Company
- Terumo Corporation Company Profile
- Owen Mumford Ltd.
- Ypsomed
- B. Braun Melsungen AG Company Profile
- HTL-STREFA
- UltiMed Inc.
- Allison Medical Inc.
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)